DSGN (Design Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

DSGN (Design Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

DSGNDesign Therapeutics, Inc.

Mkt Cap$569M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$70M

EPS (TTM)-$1.22

Free Cash Flow (TTM)-$55M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$22M
Q2 23	$0	$0	-$23M
Q3 23	$0	-$137K	-$19M
Q4 23	$0	$0	-$15M
Q1 24	$0	-$143K	-$14M
Q2 24	$0	-$151K	-$15M
Q3 24	$0	$0	-$16M
Q4 24	$0	$0	-$17M
Q1 25	$0	$0	-$20M
Q2 25	$0	-$152K	-$22M
Q3 25	$0	-$15M	-$19M
Q4 25	$0	$15M	-$18M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$17M	-$18M
Q2 23	-$14M	-$14M
Q3 23	-$15M	-$15M
Q4 23	-$13M	-$13M
Q1 24	-$12M	-$13M
Q2 24	-$11M	-$11M
Q3 24	-$10M	-$10M
Q4 24	-$10M	-$10M
Q1 25	-$17M	-$17M
Q2 25	-$14M	-$15M
Q3 25	-$11M	-$11M
Q4 25	-$12M	-$12M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$87K
Q2 23	$89K
Q3 23	$53K
Q4 23	$27K
Q1 24	$195K
Q2 24	$161K
Q3 24	$16K
Q4 24	$0
Q1 25	$72K
Q2 25	$87K
Q3 25	$0
Q4 25	$34K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+61.9%
Q2 23	—	+44.5%
Q3 23	—	-1.9%
Q4 23	—	-22.0%
Q1 24	—	-33.5%
Q2 24	—	-33.4%
Q3 24	—	-13.7%
Q4 24	—	+10.4%
Q1 25	—	+41.8%
Q2 25	—	+43.4%
Q3 25	—	+18.9%
Q4 25	—	+8.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	—
Q2 23	$0	—
Q3 23	$3M	—
Q4 23	$3M	—
Q1 24	$3M	—
Q2 24	$3M	—
Q3 24	$3M	—
Q4 24	$3M	—
Q1 25	$4M	—
Q2 25	$4M	—
Q3 25	$4M	—
Q4 25	$3M	—

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$16M	$6M	—
Q2 23	$17M	$6M	—
Q3 23	$13M	$6M	—
Q4 23	$11M	$4M	—
Q1 24	$10M	$5M	—
Q2 24	$10M	$4M	$76K
Q3 24	$12M	$4M	—
Q4 24	$12M	$5M	—
Q1 25	$15M	$5M	—
Q2 25	$16M	$6M	—
Q3 25	$15M	$5M	$70K
Q4 25	$13M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$29M	$287M	$315M
Q2 23	$27M	$276M	$303M
Q3 23	$28M	$263M	$291M
Q4 23	$21M	$261M	$282M
Q1 24	$29M	$241M	$271M
Q2 24	$46M	$215M	$261M
Q3 24	$30M	$224M	$254M
Q4 24	$23M	$223M	$245M
Q1 25	$14M	$216M	$230M
Q2 25	$20M	$197M	$216M
Q3 25	$15M	$191M	$206M
Q4 25	$17M	$203M	$220M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	56M	+0.1%
Q2 23	56M	+0.1%
Q3 23	56M	+0.1%
Q4 23	56M	+0.3%
Q1 24	56M	+0.6%
Q2 24	57M	+0.1%
Q3 24	57M	+0.1%
Q4 24	57M	+0.1%
Q1 25	57M	+0.1%
Q2 25	57M	+0.2%
Q3 25	57M	+0.2%
Q4 25	57M	+0.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$0	38
FY 22	$0	58
FY 23	$0	58
FY 24	$0	54
FY 25	$0	5K